How to build a supplement dossier that won't get rejected: a market-by-market checklist

A rejected registration dossier doesn't just delay a launch. It resets the clock, often by 6 to 12 months, in a process that was already long. And the most common reason for rejection isn't a failed ingredient: it's incomplete or incorrectly formatted documentation.

Here's what a complete dossier looks like for each of Taama's core markets, and the most common gaps we see.

The core documents every market requires

Before getting market-specific, there are documents that almost every regulatory authority requires in some form: product formulation (complete ingredient list with quantities), Certificate of Analysis (CoA) from an accredited laboratory, GMP Certificate for the manufacturing facility, Certificate of Free Sale (CFS) confirming the product is legally sold in its country of origin, stability data appropriate to the target market's climate, label artwork complying with target market requirements, and safety data for novel or high-dose ingredients in some markets.

Australia (TGA, AUST L pathway)

Required: evidence dossier supporting each listed indication (on file for audit), all ingredients on the TGA permitted list at permitted levels, label compliant with TGA requirements, Australian sponsor details.

Common gaps: indication not matching the Permissible Indications Determination exactly, ingredient at a level not covered by the permitted list, missing ARTG entry before sale commences.

Singapore (HSA)

Required: complete ingredient list with sources, CoA, GMP certificate, label artwork compliant with HSA mandatory fields, local importer or distributor details.

Common gaps: therapeutic or medicinal claims on label (not permitted for health supplements), missing advisory statement ('This is not a medicinal product'), restricted ingredient not flagged at screening stage.

Indonesia (BPOM, ML pathway)

Required: full product dossier including formulation, specs, CoA; GMP certificate accepted by BPOM; CFS apostilled; stability data (tropical conditions, 40°C/75% RH); Bahasa Indonesia label artwork; local sponsor entity; MUI halal certificate (practically required).

Common gaps: stability data in incorrect format or wrong climate zone, CFS not apostilled or from the wrong issuing authority, ingredient not on BPOM positive list, label not in Bahasa Indonesia, GMP certificate from facility not accepted by BPOM.

Malaysia (NPRA)

Required: product formulation and specifications, CoA, GMP certificate, CFS from country of origin, bilingual label artwork (English and Bahasa Malaysia), local product licence holder.

Common gaps: label only in English, claims exceeding what's permitted for NHP category, JAKIM halal not in place (distribution severely limited without it).

European Union (EFSA / national authorities)

Required: product notification to relevant national authority (varies by member state), ingredient specifications and safety data, label compliant with FIC Regulation (EU 1169/2011), health claims on the EU Register of authorised claims (EC 1924/2006).

Common gaps: health claim not on the EU authorised claims register, claim not matching authorised wording exactly, nutrient content claims not meeting qualifying criteria, PPWR packaging compliance not planned for 2030 requirements.

United States (FDA, DSHEA)

Required: structure/function claim notification to FDA (within 30 days of marketing), NDI notification if ingredient introduced after 1994, label compliant with Supplement Facts panel requirements, standard disclaimer.

Common gaps: NDI not filed for novel ingredients, structure/function claim crossing into drug claim territory, Supplement Facts panel format incorrect, FTC advertising compliance not considered alongside FDA label compliance.

Pre-submission checklist

Before submitting to any market: all ingredients screened against the target market's permitted list; CoA current and from accredited laboratory; GMP certificate valid and accepted by target authority; CFS current, correctly issued, and appropriately authenticated; stability data in the right format for target market climate; label artwork reviewed against mandatory field requirements; claims checked against permitted wording; local sponsor confirmed; halal status confirmed where relevant.

Taama checks dossier completeness before submission across 18 markets, flagging missing documents, expired certificates, and format issues before they cause a rejection. See what we cover